The scope for protective metabolic potential of the medicine plant bitter apple, aka Citrullus colocynthis, has been explored in a new review published in ‘BMC Food Production, Processing and Nutrition’.
Lonza expects to complete its $5.5bn (€5.2bn) takeover of Capsugel SA in the next few days having secured approval from competition authorities around the world.